Brief: Silo Pharma Says Spc-15 Awarded U.S. Patent
09/05/2023 13:09
May 9 (Reuters) - Silo Pharma Inc SILO.O :
* SILO PHARMA’S SPC-15 AWARDED U.S. PATENT PROTECTING
ONGOING
RESEARCH AND DEVELOPMENT OF THERAPEUTIC FOR STRESS-INDUCED
AFFECTIVE DISORDER AND ALZHEIMER’S DISEASE
Source text for Eikon: ID:nGNXbmRQ79
Further company coverage: SILO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement